At @Bristol Myers Squibb, we are all in on #TargetedProteinDegradation (TPD) and its potential for patients. As one of our differentiated research platforms, we’re expanding on our legacy in TPD by exploring potential new options across a broad range of diseases. We had great discussions about these advancements during our annual European Scientific Innovation Summit this week. You can learn more about our efforts in TPD here: Science Firsthand: The pathway to drug discovery – Bristol Myers Squibb (bms.com) #BMS_Employee, #EUScientificInnovationSummit
Wish I could have seen it, always enjoyed hearing you preach the gospel.
Super exciting Mark!
Passionate communications leader with 20+ years of experience in corporate, agencies and a foundation. Unique combination of strategic thinking, creativity and execution of large scale programs.
4moGreat Presentation on TPD, well explained.Thank you Mark!